Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,498 | 16,984 | 19,750 | 25,071 | 26,314 |
| Receivables | 569 | 586 | 635 | 231 | 2,124 |
| Other current assets | 0 | 0 | 50 | 0 | 0 |
| TOTAL | $24,782 | $18,035 | $20,971 | $25,860 | $29,145 |
| Non-Current Assets | |||||
| PPE Net | 973 | 1,069 | 1,114 | 1,120 | 1,038 |
| Intangibles | 9,417 | 9,678 | 9,985 | 8,254 | 8,507 |
| TOTAL | $10,390 | $10,747 | $11,099 | $9,373 | $9,545 |
| Total Assets | $35,172 | $28,782 | $32,020 | $35,233 | $38,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 259 | 187 | 349 | 836 | 497 |
| Accrued Expenses | 2,396 | 2,154 | 1,904 | 2,099 | 2,119 |
| TOTAL | $3,166 | $3,864 | $3,788 | $3,433 | $3,623 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 510 | 1,523 | 1,535 | 498 | 1,008 |
| TOTAL | $83 | $207 | $332 | $456 | $154 |
| Total Liabilities | $3,248 | $4,071 | $4,120 | $3,889 | $3,777 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 360 | 361 | 336 | 336 | 336 |
| Common Shares | 65 | 61 | 61 | 61 | 61 |
| Retained earnings | -200,564 | -198,448 | -195,265 | -191,903 | -188,428 |
| Other shareholders' equity | -1,286 | -228 | -222 | -136 | -43 |
| TOTAL | $31,923 | $24,711 | $27,900 | $31,344 | $34,913 |
| Total Liabilities And Equity | $35,172 | $28,782 | $32,020 | $35,233 | $38,690 |